247 related articles for article (PubMed ID: 32589760)
61. Hyponatremia: A possible immuno-neuroendocrine interface with COVID-19 in a kidney transplant recipient.
Tantisattamo E; Reddy UG; Duong DK; Ferrey AJ; Ichii H; Dafoe DC; Kalantar-Zadeh K
Transpl Infect Dis; 2020 Dec; 22(6):e13355. PubMed ID: 32510756
[TBL] [Abstract][Full Text] [Related]
62. T cell repertoire profiling in allografts and native tissues in recipients with COVID-19 after solid organ transplantation: Insight into T cell-mediated allograft protection from viral infection.
Fu J; Rust D; Fang Z; Jiao W; Lagana S; Batal I; Chen B; Merl S; Jones R; Sykes M; Weiner J
Front Immunol; 2022; 13():1056703. PubMed ID: 36591281
[TBL] [Abstract][Full Text] [Related]
63. Humoral response to SARS-CoV-2 infection among liver transplant recipients.
Becchetti C; Broekhoven AGC; Dahlqvist G; Fraga M; Zambelli MF; Ciccarelli O; Saouli AC; Trizzino A; Banz V; Dufour JF; Roukens AHE; Torres Morales SP; Myeni SK; Kikkert M; Feltkamp MCW; Coenraad MJ
Gut; 2022 Apr; 71(4):746-756. PubMed ID: 34987065
[TBL] [Abstract][Full Text] [Related]
64. A review of the clinical characteristics and management of immunosuppressed patients living with HIV or solid organ transplants infected with SARS-CoV-2 omicron variants.
Song Y; Lou L; Zhang K
Front Public Health; 2024; 12():1327093. PubMed ID: 38454994
[TBL] [Abstract][Full Text] [Related]
65. Management of immunosuppression in kidney transplant recipients with COVID-19 pneumonia: A summary of 41 confirmed cases reported worldwide.
Hu Q; Zhong Z; Xiong Y; Ye S; Wang Y; Ye Q
Transpl Infect Dis; 2021 Feb; 23(1):e13425. PubMed ID: 32702153
[TBL] [Abstract][Full Text] [Related]
66. COVID-19 in lung transplant recipients.
Myers CN; Scott JH; Criner GJ; Cordova FC; Mamary AJ; Marchetti N; Shenoy KV; Galli JA; Mulhall PD; Brown JC; Shigemura N; Sehgal S;
Transpl Infect Dis; 2020 Dec; 22(6):e13364. PubMed ID: 32521074
[TBL] [Abstract][Full Text] [Related]
67. Coronavirus Disease 2019 Vaccination Is Associated With Reduced Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Death in Liver Transplant Recipients.
John BV; Deng Y; Khakoo NS; Taddei TH; Kaplan DE; Dahman B
Gastroenterology; 2022 Feb; 162(2):645-647.e2. PubMed ID: 34758352
[No Abstract] [Full Text] [Related]
68. COVID-19 in Kidney Transplantation: Outcomes, Immunosuppression Management, and Operational Challenges.
Abu Jawdeh BG
Adv Chronic Kidney Dis; 2020 Sep; 27(5):383-389. PubMed ID: 33308503
[TBL] [Abstract][Full Text] [Related]
69. SARS-CoV-2 (COVID-19) in patients with some degree of immunosuppression.
Cajamarca-Baron J; Guavita-Navarro D; Buitrago-Bohorquez J; Gallego-Cardona L; Navas A; Cubides H; Arredondo AM; Escobar A; Rojas-Villarraga A
Reumatol Clin (Engl Ed); 2021; 17(7):408-419. PubMed ID: 34301385
[TBL] [Abstract][Full Text] [Related]
70. Liver transplant recipients infected with SARS-CoV-2 in the early postoperative period: Lessons from a single center in the epicenter of the pandemic.
Waisberg DR; Abdala E; Nacif LS; Haddad LB; Ducatti L; Santos VR; Gouveia LN; Lazari CS; Martino RB; Pinheiro RS; Arantes RM; Terrabuio DR; Malbouisson LM; Galvao FH; Andraus W; Carneiro-D'Albuquerque LA
Transpl Infect Dis; 2021 Feb; 23(1):e13418. PubMed ID: 32667716
[TBL] [Abstract][Full Text] [Related]
71. COVID-19 in Lung Transplant Recipients: A Report on 10 Recent Cases.
Reemann L; Kneidinger N; Sczepanski B; Koczulla AR
Viruses; 2024 Apr; 16(5):. PubMed ID: 38793590
[TBL] [Abstract][Full Text] [Related]
72. Immunosuppressant Management in Renal Transplant Patients with COVID-19.
Ahmadian E; Zununi Vahed S; Mammadova S; Abediazar S
Biomed Res Int; 2021; 2021():9318725. PubMed ID: 34692845
[TBL] [Abstract][Full Text] [Related]
73. A case of an Infant with SARS-CoV-2 hepatitis early after liver transplantation.
Heinz N; Griesemer A; Kinney J; Vittorio J; Lagana SM; Goldner D; Velasco M; Kato T; Lobritto S; Martinez M
Pediatr Transplant; 2020 Dec; 24(8):e13778. PubMed ID: 32559354
[TBL] [Abstract][Full Text] [Related]
74. General and Intensive Care Outcomes for Hospitalized Patients With Solid Organ Transplants With COVID-19.
Mastroianni F; Leisman DE; Fisler G; Narasimhan M
J Intensive Care Med; 2021 Apr; 36(4):494-499. PubMed ID: 33034239
[TBL] [Abstract][Full Text] [Related]
75. Evolution of pathological findings in surveillance biopsies of lung transplant recipients infected with SARS-CoV-2.
Wein AN; Liu J; Lin CY
Transpl Infect Dis; 2022 Jun; 24(3):e13823. PubMed ID: 35279033
[TBL] [Abstract][Full Text] [Related]
76. Successful implementation of preventive measures leads to low relevance of SARS-CoV-2 in liver transplant patients: Observations from a German outpatient department.
Ossami Saidy RR; Globke B; Pratschke J; Schoening W; Eurich D
Transpl Infect Dis; 2020 Dec; 22(6):e13363. PubMed ID: 32516847
[TBL] [Abstract][Full Text] [Related]
77. Management of immunosuppressants in the era of coronavirus disease-2019.
Manansala M; Baughman R; Novak R; Judson M; Sweiss N
Curr Opin Pulm Med; 2021 May; 27(3):176-183. PubMed ID: 33779588
[TBL] [Abstract][Full Text] [Related]
78. A single-center report of COVID-19 disease course and management in liver transplanted pediatric patients.
Yuksel M; Akturk H; Mizikoglu O; Toroslu E; Arikan C
Pediatr Transplant; 2021 Nov; 25(7):e14061. PubMed ID: 34076953
[TBL] [Abstract][Full Text] [Related]
79. Heart transplantation in the era of the SARS-CoV-2 pandemic: Is it safe and feasible?
Esmailian G; Kobashigawa JA; Nishihara K; Patel JK; Czer L; Megna D; Emerson D; Ramzy D; Trento A; Chikwe J; Esmailian F
Clin Transplant; 2020 Oct; 34(10):e14029. PubMed ID: 32633819
[TBL] [Abstract][Full Text] [Related]
80. Effect of immunosuppression maintenance in solid organ transplant recipients with COVID-19: Systematic review and meta-analysis.
Karruli A; Spiezia S; Boccia F; Gagliardi M; Patauner F; Salemme A; Maiello C; Zampino R; Durante-Mangoni E
Transpl Infect Dis; 2021 Aug; 23(4):e13595. PubMed ID: 33641202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
